A higher CSF p-Tau/total Tau ratio ((p-Tau/Tau)CSF) (or lower (Tau/p-Tau)CSF) was also previously described in AD patients in comparison with healthy controls41,42. This evidence concerns the gene MAPT and Alzheimer disease.